Centre Testing International Group Co. Ltd. (SHE:300012)
15.81
+0.43 (2.80%)
Apr 16, 2026, 3:04 PM CST
SHE:300012 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 6,608 | 6,067 | 5,592 | 5,121 | 4,319 |
Other Revenue | 12.64 | 16.81 | 12.54 | 10.15 | 9.78 |
| 6,621 | 6,084 | 5,605 | 5,131 | 4,329 | |
Revenue Growth (YoY) | 8.82% | 8.55% | 9.24% | 18.52% | 21.34% |
Cost of Revenue | 3,402 | 3,074 | 2,911 | 2,596 | 2,128 |
Gross Profit | 3,219 | 3,010 | 2,694 | 2,534 | 2,201 |
Selling, General & Admin | 1,510 | 1,411 | 1,304 | 1,161 | 1,045 |
Research & Development | 578.86 | 529.29 | 472.62 | 434.96 | 375.97 |
Other Operating Expenses | 38.53 | 38.16 | 33.4 | 25.37 | 22.52 |
Operating Expenses | 2,191 | 2,083 | 1,868 | 1,675 | 1,481 |
Operating Income | 1,028 | 926.61 | 825.85 | 858.82 | 719.16 |
Interest Expense | -15.56 | -15.96 | -17.5 | -14.83 | -13.62 |
Interest & Investment Income | 84.35 | 57.95 | 92.59 | 65.11 | 47.12 |
Currency Exchange Gain (Loss) | -9.2 | 2.97 | 0.25 | 7.21 | -4.86 |
Other Non Operating Income (Expenses) | -2.85 | -2.71 | -3.44 | -2.54 | -2.76 |
EBT Excluding Unusual Items | 1,085 | 968.85 | 897.75 | 913.78 | 745.04 |
Impairment of Goodwill | -22.1 | -14.25 | - | - | - |
Gain (Loss) on Sale of Investments | 2.4 | 1.57 | 14.99 | 10.65 | 19.61 |
Gain (Loss) on Sale of Assets | 2.87 | 12.08 | 2.02 | 1.46 | 0.41 |
Asset Writedown | -3.35 | -3.07 | -4.37 | -1.89 | -1.5 |
Other Unusual Items | 50.64 | 54.18 | 100.92 | 100.05 | 85.99 |
Pretax Income | 1,115 | 1,019 | 1,011 | 1,024 | 849.54 |
Income Tax Expense | 95.11 | 86.47 | 84.11 | 99.45 | 86.32 |
Earnings From Continuing Operations | 1,020 | 932.89 | 927.2 | 924.6 | 763.23 |
Minority Interest in Earnings | -3.45 | -11.81 | -16.99 | -21.86 | -17.04 |
Net Income | 1,016 | 921.07 | 910.2 | 902.73 | 746.19 |
Net Income to Common | 1,016 | 921.07 | 910.2 | 902.73 | 746.19 |
Net Income Growth | 10.35% | 1.19% | 0.83% | 20.98% | 29.18% |
Shares Outstanding (Basic) | 1,673 | 1,675 | 1,663 | 1,671 | 1,671 |
Shares Outstanding (Diluted) | 1,673 | 1,675 | 1,663 | 1,671 | 1,678 |
Shares Change (YoY) | -0.09% | 0.72% | -0.48% | -0.45% | 0.22% |
EPS (Basic) | 0.61 | 0.55 | 0.55 | 0.54 | 0.45 |
EPS (Diluted) | 0.61 | 0.55 | 0.55 | 0.54 | 0.44 |
EPS Growth | 10.46% | 0.47% | 1.31% | 21.52% | 28.91% |
Free Cash Flow | 713.09 | 371.87 | 468.92 | 458.07 | 511.74 |
Free Cash Flow Per Share | 0.43 | 0.22 | 0.28 | 0.27 | 0.30 |
Dividend Per Share | 0.200 | 0.100 | 0.100 | 0.060 | 0.060 |
Dividend Growth | 100.00% | - | 66.67% | - | 71.43% |
Gross Margin | 48.62% | 49.47% | 48.06% | 49.39% | 50.83% |
Operating Margin | 15.52% | 15.23% | 14.74% | 16.74% | 16.61% |
Profit Margin | 15.35% | 15.14% | 16.24% | 17.59% | 17.24% |
Free Cash Flow Margin | 10.77% | 6.11% | 8.37% | 8.93% | 11.82% |
EBITDA | 1,400 | 1,276 | 1,157 | 1,163 | 1,009 |
EBITDA Margin | 21.15% | 20.97% | 20.64% | 22.66% | 23.31% |
D&A For EBITDA | 372.37 | 348.97 | 330.81 | 303.85 | 289.87 |
EBIT | 1,028 | 926.61 | 825.85 | 858.82 | 719.16 |
EBIT Margin | 15.52% | 15.23% | 14.74% | 16.74% | 16.61% |
Effective Tax Rate | 8.53% | 8.48% | 8.32% | 9.71% | 10.16% |
Revenue as Reported | 6,621 | 6,084 | 5,605 | 5,131 | 4,329 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.